Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 5, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
Incidence of Non-Melanoma Skin Cancer Tallies Biggest Change From 2016 to 2017
The Global Burden of Disease 2017 study found non-melanoma skin cancer to be the biggest increase in incidence worldwide. (Source: CancerNetwork)
Source: CancerNetwork - September 27, 2019 Category: Cancer & Oncology Authors: Erin Kayata Source Type: news
Voriconazole and Non-Melanoma Skin Cancer after Allogeneic HSCT: Results of a Prospective Dedicated Follow-up Program in 302 Patients
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - September 22, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news
Machine learning method may predict skin cancer, study says
A new non-imaging method has shown accuracy in spotting skin cancer. This machine learning technique can predict the development of non-melanoma with 89 percent sensitivity (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 12, 2019 Category: Consumer Health News Source Type: news
Trump Signs 9/11 Victims Fund Extension
President Donald Trump on Monday signed legislation that will extend the September 11th Victim Compensation Fund until 2092.
During the signing ceremony at the White House, Trump was surrounding by first responders, survivors and family members of several who died in the 2001 terrorist attack on the United States.
The U.S. House of Representatives and the U.S Senate voted overwhelmingly last week to approve the legislation that will provide a lifetime of assistance for victims and their families.
The extension will allow the fund, first established in 2001, to pay for past and future medical claims of those effected by the...
Source: Asbestos and Mesothelioma News - July 29, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
9/11 Victims Fund Passes Senate
The Senate gallery erupted in applause from politicians and first responders on Tuesday after a 97-2 vote to extend the September 11 Victim Compensation Fund until 2092.
The reauthorization will fund all current and future medical claims of those effected by the 9/11 terrorist attacks on the World Trade Center in New York City, the Pentagon in Washington, and United Flight 93, which crashed in Shanksville, Pennsylvania. The extension will allow victims and their families to file claims through 2090, but they will be paid out through 2092.
The extension of funding will benefit victims who may develop mesothelioma linked to ...
Source: Asbestos and Mesothelioma News - July 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Senate Passes 9/11 Victim Compensation Fund Extension
The U.S. Senate followed the House of Representatives on Tuesday and passed legislation that will extend the September 11 Victim Compensation Fund until 2092.
The legislation will fund all current and future medical claims of those effected by the 9/11 terrorist attacks on the World Trade Center in New York City, the Pentagon in Washington, and United Flight 93, which crashed in Shanksville, Pennsylvania.
The extension of funding will benefit victims who may develop mesothelioma linked to the more than 400 tons of asbestos that covered the 16-acre disaster zone after the twin towers fell.
According to World Trade Center R...
Source: Asbestos and Mesothelioma News - July 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Sensus scores Premier contract for brachytherapy
Superficial radiation therapy provider Sensus Healthcare has signed a group...Read more on AuntMinnie.comRelated Reading:
Sensus inks R&D pact with UPenn
Sensus touts research for nonmelanoma skin cancer
FDA clears Sensus Healthcare's IORT system
Sensus names new VP of clinical development
Sensus appoints new sales VP for oncology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2019 Category: Radiology Source Type: news
Review Touts Benefits of Immunotherapy for Non-Melanoma Skin Cancers
The authors discuss the potential use and limitations of immunotherapy among patients with squamous cell cancer, basal cell carcinoma, and other skin cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Sensus inks R&D pact with UPenn
Superficial radiation therapy provider Sensus Healthcare has signed an R&D...Read more on AuntMinnie.comRelated Reading:
Sensus touts research for nonmelanoma skin cancer
FDA clears Sensus Healthcare's IORT system
Sensus names new VP of clinical development
Sensus appoints new sales VP for oncology
Sensus sells 100th system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 24, 2019 Category: Radiology Source Type: news
Potential Role of the HPV Vaccine in Preventing Non-Melanoma Skin Cancers
The association between the presence of several viruses and non-melanoma skin cancer was investigated in a recent study. (Source: CancerNetwork)
Source: CancerNetwork - April 5, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
No Elevated Cancer Risk for RA Patients With Tocilizumab (CME/CE)
(MedPage Today) -- Combined risk for new cancers except non-melanoma skin cancer with IL-6r inhibitor not significantly different than with TNF inhibitors (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 20, 2019 Category: Hematology Source Type: news
Skin cancer signs: Seven symptoms of the potentially deadly disease revealed by a doctor
SKIN cancer is caused by ultraviolet light damaging the DNA in skin cells. What ’s commonly not known is there are two types of skin cancer - melanoma skin cancer and non-melanoma skin cancer. A doctor has revealed seven symptoms to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - March 15, 2019 Category: Consumer Health News Source Type: news
Evidence on Nicotinamide for High-Risk Non-Melanoma Skin Cancers
A review published in Experimental Dermatology examined the safety and efficacy of nicotinamide in reducing non-melanoma skin cancers. (Source: CancerNetwork)
Source: CancerNetwork - March 12, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Trends in the Management of Non-Melanoma Skin Cancers
A recent review article highlighted developments in the treatment of non-melanoma skin cancers, from new chemoprevention agents to telemedicine. (Source: CancerNetwork)
Source: CancerNetwork - February 15, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
